<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>, a product of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase activity, relaxes vascular smooth muscle and elevates brain blood flow </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the importance of eNOS to cerebral blood flow augmentation after <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> infusion and increases in flow after eNOS upregulation in SV-129 mice </plain></SENT>
<SENT sid="2" pm="."><plain>Blood flow was measured by laser-Doppler flowmetry before and after <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> infusion (450 mg/kg during a 15-minute period) or measured by <z:chebi fb="32" ids="36927">14C</z:chebi>-iodoamphetamine indicator fractionation or <z:chebi fb="32" ids="36927">14C</z:chebi>-iodoantipyrine tissue equilibration techniques </plain></SENT>
<SENT sid="3" pm="."><plain>rCBF increased by 26% (laser Doppler flowmetry) after <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> infusion but did not change in mutant mice deficient in eNOS expression </plain></SENT>
<SENT sid="4" pm="."><plain>After eNOS upregulation by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="9150">simvastatin</z:chebi> treatment (2 mg/kg subcutaneously, daily for 14 days), <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> amplified and sustained the hyperemia (38%) and increased absolute brain blood flow from 86 +/- 7 to 119 +/- 10 mL/100 g per minute </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, pretreatment with <z:chebi fb="0" ids="9150">simvastatin</z:chebi> enhanced blood flow within ischemic brain tissue after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Together, these findings suggest that eNOS activity is critical for blood flow augmentation during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> infusion, and <z:hpo ids='HP_0011010'>chronic</z:hpo> eNOS upregulation combined with <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> administration provides a novel strategy to elevate cerebral blood flow in the <z:mpath ids='MPATH_458'>normal</z:mpath> and ischemic brain </plain></SENT>
</text></document>